NCT04105855

Brief Summary

Background: Many women in Sub-Saharan Africa get malaria while they are pregnant. Plasmodium falciparum is a parasite that can cause malaria. Placental malaria (PM) caused by P. falciparum can cause anemia or death in first-time mothers. In infants, it can cause low birth weight, premature birth, or other problems. Some women don t show any signs of having PM. This makes it harder to know if they might have it. Researchers want to learn how much the seasons affect the number of women and infants who get PM as well as the severity of the disease. To do this, they are going to test women and babies who visit a health center in Guinea. Objective: To learn the seasonal burden of P. falciparum infection in pregnant women and otherwise healthy infants. Eligibility: Pregnant women ages 18 years and older (or emancipated minors) and infants ages 6-12 months. Design: Participants will include women and infants who visit the health center in Maf(SqrRoot)(Registered Trademark)rinyah, Guinea, for routine care. They can take part only once per pregnancy. For screening, mothers will talk about their medical history. They will talk about their past pregnancies and their current pregnancy. They will answer questions about where they live and what they do to keep from getting malaria. Babies will be screened with their medical history and demographic information. Participants will also give a blood sample. Adults will have a finger stick. Children will have a heel stick. Or they will have blood taken from a vein. Participation will last for 1 visit to the health center.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,392

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 26, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

July 13, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

3.3 years

First QC Date

September 25, 2019

Last Update Submit

November 13, 2023

Conditions

Keywords

OrganismSeasonalBlood SmearBurdenInfectionsNatural History

Outcome Measures

Primary Outcomes (1)

  • Estimate of the seasonal burden of Plasmodium falciparum infection among pregnant women and otherwise healthy infants

    seasonal burden of Plasmodium falciparum infection

    3 years

Secondary Outcomes (1)

  • Estimate of the frequency of parasitemia due to non-falciparum malaria

    3 years

Study Arms (2)

Older Infants

Infants age 6-12 months presenting for routine healthy visits

Pregnant Women

Women 18 years and older (and emancipated minors) presenting for routine antenatal visits

Eligibility Criteria

Age6 Months+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women 18 years of age and older (including emancipated minors) and 6-12 month old infants presenting for routine visits at Maf(SqrRoot)(Registered Trademark)rinyah Health Centers

You may qualify if:

  • For pregnant women, a study participant must satisfy the following criteria to be enrolled in this study:
  • Pregnant women greater than or equal to 18 years of age (or emancipated minors) reporting for routine antenatal care at the health center without acute illness
  • The study participant understands the study and gives informed consent for participation
  • Willingness to share a positive test result for malaria or helminths with the health center in Maf(SqrRoot)(Registered Trademark)rinyah so treatment can be initiated if necessary
  • Willingness to allow stored laboratory specimens to be used for future research
  • For children, a study participant must satisfy the following criteria to be enrolled in this study:
  • Children 6-12 months of age at time of visit presenting for routine care at the health center without acute illness
  • The parent or guardian understands the study and gives informed consent for participation of their child
  • Willingness of parent/guardian to share a positive test result for malaria or helminths with the health center in Maferinyah so treatment can be initiated if necessary
  • Willingness of parent/guardian to allow stored laboratory specimens to be used for future research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maferinyah Rural Health Training and Research Center

Maferinyah, Guinea

Location

Related Publications (2)

  • Kwan JL, Seitz AE, Fried M, Lee KL, Metenou S, Morrison R, Kabyemela E, Nutman TB, Prevots DR, Duffy PE. Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania. PLoS Negl Trop Dis. 2018 Mar 26;12(3):e0006345. doi: 10.1371/journal.pntd.0006345. eCollection 2018 Mar.

    PMID: 29579050BACKGROUND
  • Rogerson SJ, Desai M, Mayor A, Sicuri E, Taylor SM, van Eijk AM. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis. 2018 Apr;18(4):e107-e118. doi: 10.1016/S1473-3099(18)30066-5. Epub 2018 Jan 31.

    PMID: 29396010BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Finger prick/heel stick samples and peripheral blood

MeSH Terms

Conditions

MalariaInfections

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesMosquito-Borne DiseasesVector Borne Diseases

Study Officials

  • Patrick E Duffy, M.D.

    National Institute of Allergy and Infectious Diseases (NIAID)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2019

First Posted

September 26, 2019

Study Start

July 13, 2020

Primary Completion

October 30, 2023

Study Completion

October 30, 2023

Last Updated

November 14, 2023

Record last verified: 2023-11

Locations